A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer

Clinical trial NCT07285148 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07285148
Sponsor: Beijing Pearl Biotechnology Limited Liability Company
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer EGFR Mutation Metastatic Lung Cancer MET Alteration

Start date: 2026-06-01
Primary completion: 2029-12-01
Enrollment: 253

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.